GSK-3β Controls Osteogenesis through Regulating Runx2 Activity

• Fumitaka Kugimiya,

  Affiliations Center for Disease Biology and Integrative Medicine, University of Tokyo, Tokyo, Japan, Sensory and Motor System Medicine, Faculty of Medicine, University of Tokyo, Tokyo, Japan

  ⨯
• Hiroshi Kawaguchi,

  Affiliation Sensory and Motor System Medicine, Faculty of Medicine, University of Tokyo, Tokyo, Japan

  ⨯
• Shinsuke Ohba,

  Affiliation Center for Disease Biology and Integrative Medicine, University of Tokyo, Tokyo, Japan

  ⨯
• Naohiro Kawamura,

  Affiliation Sensory and Motor System Medicine, Faculty of Medicine, University of Tokyo, Tokyo, Japan

  ⨯
• Makoto Hirata,

  Affiliation Sensory and Motor System Medicine, Faculty of Medicine, University of Tokyo, Tokyo, Japan

  ⨯
• Hirotaka Chikuda,

  Affiliation Sensory and Motor System Medicine, Faculty of Medicine, University of Tokyo, Tokyo, Japan

  ⨯
• Yoshiaki Azuma,

  Affiliation Teijin Institute for Biomedical Research, Tokyo, Japan

  ⨯
• James R. Woodgett,

  Affiliation Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Canada

  ⨯
• Kozo Nakamura,

  Affiliation Sensory and Motor System Medicine, Faculty of Medicine, University of Tokyo, Tokyo, Japan

  ⨯
• Ung-il Chung

  *To whom correspondence should be addressed. E-mail: uichung-tky@umin.ac.jp

  Affiliation Center for Disease Biology and Integrative Medicine, University of Tokyo, Tokyo, Japan

  ⨯